Transdermal absorption of the progestin ST-1435: Therapeutic serum steroid concentrations and high excretion of the steroid in saliva
- 30 September 1991
- journal article
- clinical trial
- Published by Elsevier in Contraception
- Vol. 44 (3) , 269-276
- https://doi.org/10.1016/0010-7824(91)90017-a
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Progesterone cream for cyclic breast pain.BMJ, 1989
- Transdermal Testosterone Therapy in the Treatment of Male Hypogonadism*Journal of Clinical Endocrinology & Metabolism, 1988
- Long-term effects of percutaneous estrogens and oral progesterone on serum lipoproteins in postmenopausal womenAmerican Journal of Obstetrics and Gynecology, 1987
- The effect of percutaneous estradiol and natural progesterone on postmenopausal bone lossAmerican Journal of Obstetrics and Gynecology, 1987
- Efficacy, acceptability, and metabolic effects of transdermal estradiol in the management of postmenopausal womenAmerican Journal of Obstetrics and Gynecology, 1985
- Endometrial responses to transdermal estradiol in postmenopausal womenAmerican Journal of Obstetrics and Gynecology, 1985
- Pharmacokinetic observations on ST-1435 administered subcutaneously and intravaginallyContraception, 1984
- Intestinal absorption of ST-1435 in ratsContraception, 1984
- Contraception with subcutaneous capsules containing ST-1435. Pituitary and ovarian function and plasma levels of ST-1435Contraception, 1981
- In VivoStudies on Progesterone Metabolism by Human SkinJournal of Clinical Endocrinology & Metabolism, 1969